The influence of commensal bacteria on infection with enteric viruses

Nature Reviews Microbiology

Volumn 14, Issue 4, 2016, Pages 197-204

  Karst, Stephanie M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRUS ANTIBODY; VIRUS VACCINE; ANTIVIRUS AGENT;

ANTIBODY PRODUCTION; ARTICLE; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIUM; CELL STIMULATION; COMMENSALISM; ENTERIC VIRUS; HUMAN; IMMUNOLOGICAL TOLERANCE; INTESTINE FLORA; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS PARTICLE; ANIMAL; DRUG EFFECTS; ENTEROVIRUS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MOUSE; PATHOGENICITY; VIROLOGY; VIRUS DISEASES;

ANIMALS; ANTIVIRAL AGENTS; ENTEROVIRUS; GASTROINTESTINAL MICROBIOME; HOST-PATHOGEN INTERACTIONS; HUMANS; INTESTINES; MICE; VIRUS DISEASES;

EID: 84961052700     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro.2015.25     Document Type: Article

References (65)

1. Qin J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 464, 59-65 (2010).
2. Norman J. M, Handley S. A, & Virgin H. W. Kingdom-Agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology. 146, 1459-1469 (2014).
3. Kau A. L, Ahern P. P, Griffin N. W, Goodman A. L, & Gordon J. I. Human nutrition, the gut microbiome and the immune system. Nature. 474, 327-336 (2011).
4. Sommer F, & Bäckhed F. The gut microbiota - masters of host development and physiology. Nat. Rev. Microbiol. 11, 227-238 (2013).
5. Nicholson J. K, et al. Host-gut microbiota metabolic interactions. Science. 336, 1262-1267 (2012).
6. Tremaroli V, & Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 489, 242-249 (2012).
7. Hooper L. V, Littman D. R, & Macpherson A. J. Interactions between the microbiota and the immune system. Science. 336, 1268-1273 (2012).
8. Kamada N, & Núñez G. Regulation of the immune system by the resident intestinal bacteria. Gastroenterology. 146, 1477-1488 (2014).
9. Round J. L, & Mazmanian S. K. Inducible Foxp3+ regulatory T cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA. 107, 12204-12209 (2010).
10. Vaishnava S, et al. The antibacterial lectin RegIII? promotes the spatial segregation of microbiota and host in the intestine. Science. 334, 255-258 (2011).
11. Hooper L. V, Stappenbeck T. S, Hong C. V, & Gordon J. I. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 4, 269-273 (2003).
12. Tate J. E, et al. 2008 estimate of worldwide rotavirus-Associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-Analysis. Lancet Infect. Dis. 12, 136-141 (2012).
13. Lanata C. F, et al. Global causes of diarrheal disease mortality in children 5 years of age: a systematic review. PLoS ONE 8, e72788 (2013).
14. Payne D. C, et al. Norovirus and medically attended gastroenteritis in U.S. children. N. Engl. J. Med. 368, 1121-1130 (2013).
15. Koo H. L, et al. Noroviruses: the most common pediatric viral enteric pathogen at a large university hospital after introduction of rotavirus vaccination. J. Pediatr. Infect. Dis. Soc. 2, 57-60 (2013).
16. Koo H. L, Ajami N, Atmar R. L, & DuPont H. L. Noroviruses: the leading cause of foodborne disease worldwide. Discov. Med. 10, 61-70 (2010).
17. Ahmed S. M, et al. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-Analysis. Lancet Infect. Dis. 14, 725-730 (2014).
18. Bosch A, Pintó R. M, & Guix S. Human astroviruses. Clin. Microbiol. Rev. 27, 1048-1074 (2014).
19. Ross S. R. Mouse mammary tumor virus molecular biology and oncogenesis. Viruses. 2, 2000-2012 (2010).
20. Kuss S. K, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science. 334, 249-252 (2011).
21. Kane M, et al. Successful transmission of a retrovirus depends on the commensal microbiota. Science. 334, 245-249 (2011).
22. Uchiyama R, Chassaing B, Zhang B, & Gewirtz A. T. Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J. Infect. Dis. 210, 171-182 (2014).
23. Jones M. K, et al. Enteric bacteria promote human and murine norovirus infection of B cells. Science. 346, 755-759 (2014).
24. Kernbauer E, Ding Y, & Cadwell K. An enteric virus can replace the beneficial function of commensal bacteria. Nature. 516, 94-98 (2014).
25. Baldridge M. T, et al. Commensal microbes and interferon ? determine persistence of enteric murine norovirus infection. Science. 347, 266-269 (2015).
26. Robinson C. M, Jesudhasan P. R, & Pfeiffer J. K. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe. 15, 36-46 (2014).
27. Tan M, & Jiang X. Norovirus and its histo-blood group antigen receptors: an answer to a historical puzzle. Trends Microbiol. 13, 285-293 (2005).
28. Miura T, et al. Histo-blood group antigen-like substances of human enteric bacteria as specific adsorbents for human noroviruses. J. Virol. 87, 9441-9451 (2013).
29. Karst S. M. Identification of a novel cellular target and a co factor for norovirus infection - B cells and commensal bacteria. Gut Microbes. 6, 266-271 (2015).
30. Abreu M. T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131-144 (2010).
31. Mukherji A, Kobiita A, Ye T, & Chambon P. Homeostasis in intestinal epithelium is orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell. 153, 812-827 (2013).
32. Takahashi T, et al. Immunologic self-Tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
33. Thornton A. M, & Shevach E. M. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190 (2000).
34. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, & Yamaguchi T. Regulatory T cells: how do they suppress immune responses? Int. Immunol. 21, 1105-1111 (2009).
35. Caridade M, Graca L, & Ribeiro R. M. Mechanisms underlying CD4+ Treg immune regulation in the adult: from experiments to models. Front. Immunol. 4, 378 (2013).
36. Jude B. A, et al. Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4, 573-578 (2003).
37. Wilks J, et al. Mammalian lipopolysaccharide receptors incorporated into the retroviral envelope augment virus transmission. Cell Host Microbe. 18, 456-462 (2015).
38. Blacklow N. R, et al. Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann. Intern. Med. 76, 993-1008 (1972).
39. Dolin R, Levy A. G, Wyatt R. G, Thornhill T. S, & Gardner J. D. Viral gastroenteritis induced by the Hawaii agent. Jejunal histopathology and serologic response. Am. J. Med. 59, 761-768 (1975).
40. Schreiber D. S, Blacklow N. R, & Trier J. S. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N. Engl. J. Med. 288, 1318-1323 (1973).
41. Mumphrey S. M, et al. Murine norovirus 1 infection is associated with histopathological changes in immunocompetent hosts, but clinical disease is prevented by STAT1 dependent interferon responses. J. Virol. 81, 3251-3263 (2007).
42. Souza M, Azevedo M. S. P, Jung K, Cheetham S, & Saif L. J. Pathogenesis and immune responses in gnotobiotic calves after infection with the genogroup II.4 HS66 strain of human norovirus. J. Virol. 82, 1777-1786 (2008).
43. Troeger H, et al. Structural and functional changes of the duodenum in human norovirus infection. Gut. 58, 1070-1077 (2009).
44. Kahan S. M, et al. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology. 421, 202-210 (2011).
45. Basic M, et al. Norovirus triggered microbiota-driven mucosal inflammation in interleukin 10 deficient mice. Inflamm. Bowel Dis. 20, 431-443 (2014).
46. Nice T. J, et al. Interferon-? cures persistent murine norovirus infection in the absence of adaptive immunity. Science. 347, 269-273 (2015).
47. Wobus C. E, et al. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol. 2, e432 (2004).
48. Bok K, et al. Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc. Natl Acad. Sci. USA. 108, 325-330 (2011).
49. Duizer E, et al. Laboratory efforts to cultivate noroviruses. J. Gen. Virol. 85, 79-87 (2004).
50. Pott J, et al. IFN determines the intestinal epithelial antiviral host defense. Proc. Natl Acad. Sci. USA. 108, 7944-7949 (2011).
51. Zhang B, et al. Prevention and cure of rotavirus infection via TLR5/NLRC4-mediated production of IL 22 and IL 18. Science. 346, 861-865 (2014).
52. Johansson M. E. V, et al. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc. Natl Acad. Sci. USA. 105, 15064-15069 (2008).
53. Blumershine R. V, & Savage D. C. Filamentous microbes indigenous to the murine small bowel: a scanning electron microscopic study of their morphology and attachment to the epithelium. Microb. Ecol. 4, 95-103 (1977).
54. Klaasen H. L. B. M, Koopman J. P, Poelma F. G. J, & Beynen A. C. Intestinal, segmented, filamentous bacteria. FEMS Microbiol. Rev. 8, 165-179 (1992).
55. Kaparakis-Liaskos M, & Ferrero R. L. Immune modulation by bacterial outer membrane vesicles. Nat. Rev. Immunol. 15, 375-387 (2015).
56. Schwechheimer C, & Kuehn M. J. Outer-membrane vesicles from Gram-negative bacteria: biogenesis and functions. Nat. Rev. Microbiol. 13, 605-619 (2015).
57. Mabbott N. A, Donaldson D. S, Ohno H, Williams I. R, & Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 6, 666-677 (2013).
58. Golovkina T. V, Shlomchik M, Hannum L, & Chervonsky A. Organogenic role of B lymphocytes in mucosal immunity. Science. 286, 1965-1968 (1999).
59. Gonzalez-Hernandez M. B, et al. Murine norovirus transcytosis across an in vitro polarized murine intestinal epithelial monolayer is mediated by M like cells. J. Virol. 87, 12685-12693 (2013).
60. Gonzalez-Hernandez M. B, et al. Efficient norovirus and reovirus replication in the mouse intestine requires microfold (M) cells. J. Virol. 88, 6934-6943 (2014).
61. Siciński P, et al. Poliovirus type 1 enters the human host through intestinal M cells. Gastroenterology. 98, 56-58 (1990).
62. Wolf J. L, et al. Intestinal M cells: a pathway for entry of reovirus into the host. Science. 212, 471-472 (1981).
63. Marionneau S, et al. Norwalk virus binds to histo-blood group antigens present on gastroduodenal epithelial cells of secretor individuals. Gastroenterology. 122, 1967-1977 (2002).
64. Tamura M, Natori K, Kobayashi M, Miyamura T, & Takeda N. Interaction of recombinant norwalk virus particles with the 105 kilodalton cellular binding protein, a candidate receptor molecule for virus attachment. J. Virol. 74, 11589-11597 (2000).
65. White L. J, et al. Attachment and entry of recombinant norwalk virus capsids to cultured human and animal cell lines. J. Virol. 70, 6589-6597 (1996).